胆固醇组合治疗的毒性风险:使用不成比例性和相互作用评估的USFDA不良事件报告系统分析
1Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
Expert opinion on drug safety
|April 26, 2025
概括
胆固醇与某些抗生素的结合会增加急性功能衰竭的风险. 仔细监测至关重要,特别是对于塞夫塔齐迪姆,万科米辛和提格环素,由于严重的毒性问题.
科学领域:
- 药物监督 药物监督 药物监督
- 腎臟病學 (nephrology) 是一種醫學.
- 传染性疾病 传染性疾病
背景情况:
- 胆固醇是一种针对多药耐药性感染的关键抗生素.
- 科利斯在组合治疗中的使用引发了由于潜在的毒性而引起的担忧.
研究的目的:
- 评估与胆固醇-抗微生物组合相关的急性功能衰竭 (ARF) 的风险.
- 评估接受胆固醇结合疗法的患者的药物相互作用和临床结果.
主要方法:
- 从美国FDA的不良事件报告系统 (AERS) 中回顾分析了29,163,222份报告.
- 不成比例分析 (频率主义和贝叶斯主义) 来评估ARF风险.
- 使用相互作用调整信号得分 (INTSS) 和死亡率数据评估药物相互作用.
主要成果:
- 观察到与塞夫塔齐,万科米辛,美罗和tigecycline结合的胆固醇组合有显著更高的ARF风险.
- 对于ARF风险的最强烈信号是发现了胆固醇 - 塞夫塔齐迪姆组合.
- 矛盾的是,在没有毒性抗微生物药物治疗胆固醇的患者中,死亡率更高.
结论:
- 胆固醇与塞夫塔齐迪姆,万科米辛和提格环素的组合存在显著的毒性风险.
- 仔细的临床考虑和严格的脏监测对于这些组合疗法至关重要.
- 管理胆固醇组合疗法需要对功能保持警,特别是在重症患者中.
相关概念视频
Pharmacovigilance
739
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
739
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Renal Failure: Dose Adjustments
35
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
35
Nonlinear Pharmacokinetics: Overview
197
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
197
Drug Regulation
1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Nonlinear Pharmacokinetics: Causes of Nonlinearity
77
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
77


